Brian Adams
CIK 1636994 · Chief Legal Officer · last filed 2026-03-04
Brian Adams is a Chief Legal Officer who has filed 74 SEC Form 4 insider transactions across 3 companies since 2015. The most recent filing, for KYMR, was dated Mar 4, 2026. Across all open-market trades the lifetime net is −$2.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $10.7M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$10.65M
3
74
-$2.08M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| KYMR | Chief Legal Officer | 56,625 | $86.20 | $4.88M | $0 | 2 | 2026-03-04 |
| RLAY | Chief Legal Officer | 389,748 | $14.81 | $5.77M | -$1.82M | 45 | 2025-07-30 |
| KERYX BIOPHARMACEUTICALS INC (KERX) Delisted | General Counsel and Secretary | 126,069 | — | — | -$262.5K | 27 | 2018-02-16 |
Recent Filings
74 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-03-04 | KYMR | Grant (A) | +4,125 | $0 | EDGAR |
| 2025-09-03 | KYMR | Grant (A) | +52,500 | $0 | EDGAR |
| 2025-07-30 | RLAY | Sell (S) | −19,913 | -$73.4K | EDGAR |
| 2025-04-30 | RLAY | Sell (S) | −14,587 | -$44.0K | EDGAR |
| 2025-03-31 | RLAY | Sell (S) | −298 | -$846 | EDGAR |
| 2025-01-30 | RLAY | Mixed | +84,662 | -$247.9K | EDGAR |
| 2025-01-14 | RLAY | Grant (A) | — | $0 | EDGAR |
| 2024-12-31 | RLAY | Sell (S) | −299 | -$1.3K | EDGAR |
| 2024-10-30 | RLAY | Sell (S) | −1,632 | -$9.9K | EDGAR |
| 2024-10-01 | RLAY | Sell (S) | −295 | -$2.2K | EDGAR |